Zhenduo Lu

机构：Zhengzhou University, Henan Cancer Hospital

发表论文 55 篇 · 总被引 359 次 · h-index 13

代表论文

• Neoadjuvant camrelizumab plus nab-paclitaxel and epirubicin in early triple-negative breast cancer: a single-arm phase II trial (2023 · Nature Communications · 被引 34)
• Application of Neoadjuvant Docetaxel plus Cisplatin in Early-Stage Triple-Negative Breast Cancer (HELEN-001): Results from a Phase II Trial (2025 · Clinical Cancer Research · 被引 4)
• Targeted axillary dissection after neoadjuvant chemotherapy for highly selective patients with initial cN1 breast cancer: A single-center prospective trial (2024 · Chinese Medical Journal · 被引 2)
• Neoadjuvant pyrotinib vs pertuzumab therapy for HER2-positive early breast cancer: The HELEN HER-013 randomized clinical trial. (2026 · Journal of Clinical Oncology · 被引 1)
• SHR-A1811 as neoadjuvant therapy for HR-positive, HER2-low breast cancer: A single-arm, phase II clinical study. (2025 · Journal of Clinical Oncology · 被引 1)
• A comparative study of mitoxantrone hydrochloride injection and technetium-99 m for tracing axillary sentinel nodes in patients with breast cancer (2025 · BMC Cancer · 被引 1)